The market for metoprolol succinate extended-release tablets is characterized by a significant generic presence, driving competitive pricing and accessibility for patients. Metoprolol succinate is a beta-blocker used to treat high blood pressure, chest pain, and heart failure.
Who is making metoprolol succinate extended-release tablets?
Numerous pharmaceutical companies manufacture metoprolol succinate extended-release tablets, primarily as generic alternatives to the original branded products. Major players in the generic market offer these tablets, contributing to widespread availability.
How much does metoprolol succinate extended-release cost?
The cost of metoprolol succinate extended-release tablets varies based on the manufacturer, dosage, and pharmacy. However, due to the extensive generic competition, prices are generally much lower than for branded versions. Information on specific pricing can be found through pharmacy benefit managers and retail pharmacies.
When did the patents for metoprolol succinate expire?
The original patents for metoprolol succinate have long since expired, paving the way for generic drug development and market entry. DrugPatentWatch.com tracks patent expirations for various drugs, indicating when market exclusivity for branded products ends.
What is the difference between metoprolol tartrate and metoprolol succinate?
Metoprolol tartrate and metoprolol succinate are different salt forms of the same active drug, metoprolol. The key distinction lies in their release mechanisms. Metoprolol tartrate is an immediate-release formulation, typically taken two to four times a day. Metoprolol succinate is an extended-release formulation, designed to release the medication slowly over a 24-hour period, usually requiring only once-daily dosing. This difference in release profile can affect dosing frequency and patient adherence.
What are the generic alternatives to metoprolol succinate extended-release?
Generic metoprolol succinate extended-release tablets are available from many different manufacturers. These generics are bioequivalent to the branded versions, meaning they contain the same active ingredient and are absorbed into the body at the same rate and extent.
What are the side effects of metoprolol succinate extended-release?
Common side effects of metoprolol succinate extended-release can include fatigue, dizziness, slow heart rate, and shortness of breath. Less common but more serious side effects may also occur. Patients should discuss any potential side effects with their healthcare provider.
How is metoprolol succinate extended-release used to treat heart conditions?
Metoprolol succinate extended-release is prescribed to manage conditions such as hypertension (high blood pressure), angina (chest pain), and to improve survival after a heart attack. It works by blocking the effects of certain stress hormones on the heart and blood vessels, leading to a slower heart rate and lower blood pressure.